• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Studies on the effect of uremia on phenylbutazone and aminophenazone metabolism in man].

作者信息

Leber H W, Harders A, Schütterle G

出版信息

Klin Wochenschr. 1972 Dec 1;50(23):1092-6. doi: 10.1007/BF01486853.

DOI:10.1007/BF01486853
PMID:4643487
Abstract
摘要

相似文献

1
[Studies on the effect of uremia on phenylbutazone and aminophenazone metabolism in man].
Klin Wochenschr. 1972 Dec 1;50(23):1092-6. doi: 10.1007/BF01486853.
2
[Aminophenazone metabolism in chronic insufficiency of the right heart].
Z Gesamte Inn Med. 1971 Nov 1;26(21):Suppl:298-300.
3
[Chronic kidney failure and absorption of aminophenazone].
Z Gesamte Inn Med. 1971 Nov 1;26(21):Suppl:296-8.
4
Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Clin Nephrol. 1976 Sep;6(3):388-93.
5
The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.保泰松固体剂型的生理有效性。II. 体内生理有效性与体外溶出参数的相关性。
J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):187-96.
6
Impairment of human drug metabolism by oral contraceptive steroids.口服避孕类固醇对人体药物代谢的损害。
Clin Pharmacol Ther. 1972 Jul-Aug;13(4):552-7. doi: 10.1002/cpt1972134552.
7
[Changes in aminophenazone metabolism with acute hepatitis in children (author's transl)].
Dtsch Med Wochenschr. 1977 Oct 14;102(41):1460-4. doi: 10.1055/s-0028-1105522.
8
Phenylbutazone: factors influencing plasma concentrations.保泰松：影响血浆浓度的因素
J Int Med Res. 1977;5 Suppl 2:15-9.
9
[Studies on the combination of drugs. VI. Effect of 4-hydroxyantipyrine etheral derivatives on metabolism of aminopyrine, phenacetin, acetanilide, and phenylbutazone].
Yakugaku Zasshi. 1968 Jul;88(7):847-51. doi: 10.1248/yakushi1947.88.7_847.
10
[Aminophenazone half life in patients with chronic liver parenchyma disorders].
Z Gesamte Inn Med. 1972 Oct 1;27(19):849-53.

引用本文的文献

1
Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone).吡唑啉酮类（保泰松、氨基比林和安乃近）的动力学与代谢
Br J Clin Pharmacol. 1980 Oct;10 Suppl 2(Suppl 2):299S-308S. doi: 10.1111/j.1365-2125.1980.tb01813.x.
2
Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.[4-14C]莫比布宗口服给药后在人体的药代动力学。
Eur J Drug Metab Pharmacokinet. 1984 Jul-Sep;9(3):223-7. doi: 10.1007/BF03189645.
3
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.非甾体抗炎药的临床药代动力学

本文引用的文献

1
The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material.氨基比林（匹拉米洞）在人体内的代谢情况以及生物材料中氨基比林及其代谢产物的测定方法。
J Pharmacol Exp Ther. 1950 Jun;99(2):171-84.
2
Gastrointestinal lesions occurring in uremia.尿毒症时出现的胃肠道病变。
Ann Intern Med. 1952 Jul;37(1):96-105. doi: 10.7326/0003-4819-37-1-96.
3
DISAPPEARANCE RATE OF TOLBUTAMIDE IN NORMAL SUBJECTS AND IN DIABETES MELLITUS, LIVER CIRRHOSIS, AND RENAL DISEASE.甲苯磺丁脲在正常受试者以及糖尿病、肝硬化和肾脏疾病患者中的消失率
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
4
Assessment of liver ability to biotransformation of antipyrine in uraemic patients on regular peritoneal dialysis treatment.
Int Urol Nephrol. 1989;21(5):541-5. doi: 10.1007/BF02549593.
5
Clinical pharmacokinetics of phenylbutazone.保泰松的临床药代动力学
Clin Pharmacokinet. 1978 Sep-Oct;3(5):369-80. doi: 10.2165/00003088-197803050-00003.
Diabetes. 1963 Sep-Oct;12:414-9. doi: 10.2337/diab.12.5.414.
4
Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.苯巴比妥及其他药物诱导的药物代谢酶适应性增加。
J Pharmacol Exp Ther. 1960 Sep;130:1-8.
5
Effect of azotemia upon the action of intravenous barbiturate anesthesia.氮质血症对静脉注射巴比妥类麻醉作用的影响。
Anesthesiology. 1954 Jul;15(4):333-46. doi: 10.1097/00000542-195407000-00001.
6
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.保泰松（布他唑立丁）在人体中的生理处置及其在生物材料中的测定方法。
J Pharmacol Exp Ther. 1953 Nov;109(3):346-57.
7
Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.肝脏药物氧化机制及其与人氧化速率个体差异的关系。
Ann N Y Acad Sci. 1971 Jul 6;179:411-20. doi: 10.1111/j.1749-6632.1971.tb46918.x.
8
Oxidative drug metabolism in liver microsomes from uremic rats.尿毒症大鼠肝微粒体中的药物氧化代谢。
Kidney Int. 1972 Sep;2(3):152-8. doi: 10.1038/ki.1972.85.
9
Effect of adrenalectomy and cortisone administration on components of the liver microsomal mixed function oxygenase system of male rats which catalyzes ethylmorphine metabolism.肾上腺切除术及给予可的松对催化乙基吗啡代谢的雄性大鼠肝脏微粒体混合功能氧化酶系统各组分的影响。
Biochem Pharmacol. 1970 Aug;19(8):2461-7. doi: 10.1016/0006-2952(70)90271-6.
10
Pharmacological implications of microsomal enzyme induction.微粒体酶诱导的药理学意义。
Pharmacol Rev. 1967 Sep;19(3):317-66.